Please provide your email address to receive an email when new articles are posted on . Among patients with pulmonary alveolar proteinosis, treatment with daily inhaled recombinant human ...
Extract: Serial studies of arterial and alveolar oxygen, carbon dioxide, and nitrogen tensions, arterial pH, and ratios of dead space: tidal volume were made in 24 nondistressed premature infants. By ...
The safety and efficacy of Molgradex was evaluated in a double blind, placebo controlled trial involving 138 patients with aPAP. Savara Inc. announced topline data from the pivotal phase 3 trial, ...
A discrepancy between the predicted ventilation standards and the actual ventilation requirements may be caused by an increase in the physiologic dead space or by an increased carbon dioxide ...
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced a manuscript titled, ...
In a retrospective study of 100 patients treated with prolonged mechanical ventilation, water retention without evidence of cardiac failure developed in 19. This was associated with radiologic ...
-- Real World, Retrospective Outcomes Data Suggest Molgramostim Addresses the Underlying Pathophysiology of aPAP Resulting in Improved Lung Function, Decreased Disease Burden, Restored Patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results